To compare the quality of life of patients with obsessive–compulsive disorder (OCD) with and without depression comorbidity.
Method:
Treatment-seeking outpatients (n = 56) with OCD (n = 28) or comorbid OCD and major depressive disorder (MDD) (n = 28), matched by age, sex, and antidepressant medication use, completed a multidimensional measure of quality of life.
Results:
Patients with comorbid OCD and MDD reported significantly greater decrements in their subjective feelings, social relations, and a composite measure of general activities (for example, overall well-being and life satisfaction) in comparison with patients with OCD without MDD. These differences were not owing to the presence of other Axis I comorbid disorders.
Conclusions:
Treatments addressing depression comorbidity in the context of primary OCD are required to improve the quality of life of this severely affected population of OCD sufferers.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Revised. Washington (DC): APA; 2000.
2.
National Advisory Mental Health Council. Health care reform for Americans with severe mental illnesses: Report of the National Advisory Mental Health Council. Am J Psychiatry. 1993;150:1447–1465.
3.
HanssonL.Quality of life in depression and anxiety. Int Rev Psychiatry. 2002;14:185–189.
4.
MendlowiczMVSteinMB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157:669–682.
5.
Stengler-WenzkeKKrollMMatschingerH, Subjective quality of life of patients with obsessive–compulsive disorder. Soc Psychiatry Psychiatr Epidemiol. 2006;41:662–668.
6.
OlatunjiBOCisleJMTolinDF. Quality of life in the anxiety disorders: A meta-analytic review. Clin Psychol Rev. 2007;27:572–581.
7.
EisenJLManceboMAPintoA, Impact of obsessive–compulsive disorder on quality of life. Compr Psychiatry. 2006;47:270–275.
8.
MasellisMRectorNARichterMA. Quality of life in OCD: Differential impact of obsessions, compulsions, and depression comorbidity. Can J Psychiatry. 2003;28:72–77.
9.
KoranLMThienemannMLDavenportR.Quality of life for patients with obsessive–compulsive disorder. Am J Psychiatry. 1996;53:783–788.
10.
BlackDWNoyesRGoldsteinRB, A family study of obsessive–compulsive disorder. J Affect Disord. 1992;49:362–368.
11.
CrinoRDAndrewsG.Obsessive–compulsive disorder and Axis I comorbidity. J Anxiety Disord. 1996;10:37–46.
12.
PerugiGAkiskalHSPfannerC, The clinical impact of bipolar and unipolar affective comorbidity on obsessive–compulsive disorder. J Affect Disord. 1997;46:15–23.
13.
RasmussenSATsuangMT. Clinical characteristics and family history in DSM-III obsessive–compulsive disorder. Am J Psychiatry. 1986;143:317–322.
14.
ReigerDABoydJHBurkeJDJrOne-month prevalence of mental disorders in the United States: Based on five epidemiologic catchment area sites. Arch Gen Psychiatry. 1988;45:977–986.
15.
WeissmanMM. Cross-national epidemiology of obsessive–compulsive disorder. CNS Spectr. 1994;3(S1):6–9.
16.
WelnerAReichRRobinsE, Obsessive-compulsive neurosis: Record, follow-up, and family studies. I. Inpatient record study. Compr Psychiatry. 1976;17:527–539.
17.
ChenYWDisalverSC. Comorbidity for obsessive–compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59:57–64.
18.
StavrakiCVargoB.The relationships of anxiety and depression: A review of the literature. Br J Psychiatry. 1986;149:7–16.
19.
WittchenHUEssauL.Natural course and spontaneous remissions of untreated anxiety disorders. In: HandIWittchenHU, editors. Panic and phobias. Berlin (DE): Springer Verlag; 1989.
20.
AbramowitzJSFoaEB. Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD?Behav Ther. 2000;31:795–800.
21.
OverbeekTShruersKVermettenE, Comorbidity of obsessive–compulsive disorder and depression: Prevalence, symptom severity, and treatment effect. J Clin Psychiatry. 2002;63:1106–1112.
22.
FranklinMEAbramowitzJSKozakMJ, Effectiveness of exposure and ritual prevention for obsessive–compulsive disorder: Randomized compared with nonrandomized samples. J Consult Clin Psychol. 2000;68:594–602.
23.
AntonyMMRothDSwinsonRP, Illness intrusiveness in individuals with panic disorder, obsessive–compulsive disorder, or social phobia. J Nerv Ment Dis. 1998;186:311–315.
24.
EndicottJNeeJHarrisonW, Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacol Bull. 1993;29:321–326.
25.
BeckATSteerRABrownGK. Beck Depression Inventory: Second edition manual. San Antonio (TX): The Psychological Corporation; 1996.
26.
DozoisDJADobsonKSAhnbergMJL. A psychometric evaluation of the Beck Depression Inventory-II. Psychol Assess. 1998;10:83–89.
27.
GoodmanWKPriceLHRasmussenSA, The Yale-Brown Obsessive Compulsive Scale: Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006–1011.
28.
GoodmanWKPriceLHRasmussenSA, The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989;46:1012–1016.
29.
RapaportMHClaryCFayyadR, Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005;162:1171–1178.
30.
Nolen-HoeksemaS.Responses to depression and their effects on the duration of depressive episodes. J Abnorm Psychol. 1991;100:569–582.
31.
AckermanDLGreenlandS.Mulitvariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharm. 2002;22:300–317.
32.
AbramowitzJS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. J Consult Clin Psychol. 1997;65:44–52.
33.
FoaEBLiebowitzMRKozakMJ, Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder. Am J Psychiatry. 2005;162:151–161.
34.
DiefenbachGJAbramowitzJSNorbergMM, Changes in quality of life following cognitive-behavioral therapy for obsessive–compulsive disorder. Behav Res Ther. 2007;45:3060–3068.
35.
MoritzSRuferMFrickeS, Quality of life in obsessive–compulsive disorder before and after treatment. Compr Psychiatry. 2005;46:453–459.
36.
KaplanAHollanderE.A review of pharmacologic treatments for obsessive–compulsive disorder. Focus. 2004;2:454–461.
37.
BlochMHLanderos-WeisenbergerAKelmendiB, A systematic review: Antipsychotic augmentation with treatment-refractory obsessive–compulsive disorder. Mol Psychiatry. 2006;11:622–632.
38.
AbramowitzJS. Treatment of obsessive–compulsive disorder in patients who have comorbid depression. J Clin Psychol. 2004;60:1133–1141.
39.
RectorNACassinSERichterMA. Treatment of obsessive-compulsive disorder in patients with comorbid depression: A pilot randomized controlled trial. Forthcoming. 2009.
